Dr. Pokov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6821 Reisterstown Rd
Ste 206
Baltimore, MD 21215Phone+1 410-358-9158Fax+1 410-358-6350
Education & Training
- Lehigh Valley Health NetworkResidency, Internal Medicine, 1997 - 1999
- University of Maryland Medical Center Midtown CampusInternship, Transitional Year, 1996 - 1997
- National Medical University KievClass of 1972
Certifications & Licensure
- MD State Medical License 1999 - 2025
Publications & Presentations
PubMed
- 7 citationsClopidogrel, prasugrel, ticagrelor or vorapaxar in patients with renal impairment: do we have a winner?Victor L. Serebruany, Aleš Tomek, Alex N. Pokov, Moo Hyun Kim
Expert Review of Cardiovascular Therapy. 2015-10-29 - Effect of aliskiren and valsartan combination versus aliskiren monotherapy on hemostatic biomarkers in hypertensive diabetics: Aliskiren and Valsartan Impact in Diabet...Victor L. Serebruany, Alex N. Pokov, Dániel Aradi, Mehmet Mustafa Can, James J. DiNicolantonio
American Journal of Therapeutics. 2014-12-04 - 11 citationsDisbalance between mortality and non-fatal vascular events in the CHAMPION-PHOENIX trial: the cangrelor efficacy challenge.Victor L. Serebruany, Alex N. Pokov, Seth D. Fortmann, James J. DiNicolantonio
Thrombosis and Haemostasis. 2013-11-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: